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Amphiphilic detergent-soluble acetylcholinesterase (AChE) from Torpedo is converted to a hydrophilic form 
by digestion with phospholipase C from Trypanosoma brucei or from Bacillus cereus. This lipase digestion 
uncovers an immunological determinant which crossreacts with a complex carbohydrate structure present 
in the hydrophilic form of all variant surface glycoproteins (VSG) of T. brucei. This crossreacting determi- 
nant is also detected in human erythrocyte AChE after digestion with T. brucei lipase. From these results 
we conclude that the glycophospholipid anchors of protozoan VSG and of AChE of the two vertebrates 
share common structuraf eatures, suggesting that this novel type of membrane anchor has been conserved 
during evolution. 
Acetylchohnesterase Phospholipase C Surface glycoprotein (Trypanosoma brucei) 
Crossreacting determinant 
1. INTRODUCTION 
The membrane-bound, amphiphilic form of 
AChE can be solubilized with detergent, by pro- 
teolytic treatment and by the action of PI-specific 
phospholip~e C (review [ 11). This has been shown 
with AChE from Torpedo electric organ as well as 
from red cell membranes. The release of AChE by 
PI-specific phospholipase C suggests that it is an- 
chored to the membrane via a direct and specific 
interaction with PI [2,3]. A completely different 
type of protein, the variant surface glycoproteins 
(VSGs) of African trypanosomes which are re- 
sponsible for antigenic variation, seems to be at- 
Abbre~~at~o~: DS-AChE, detergent-soluble acetyl- 
cholinesterase; VSG, variant surface glycoprotein; PI, 
phosphatidylinositol 
k&Mb&e anchoring _ 
tached to the membranes in a similar manner. 
They contain at the C-terminus a common glyco- 
phospholipid composed of ethanolamine, man- 
nose, glucosamine, galactose, phosphate and 
dim~istyl-PI which anchors the VSGs to the 
plasma membrane [4,5]. Following cell lysis an en- 
dogenous phospholipase C cleaves dimyristylgly- 
cerol from the glycophospholipid and converts the 
membrane-bound form of VSG into its soluble 
form [4,5]. This event exposes an antigenic cross- 
reacting determinant on the carbohydrate moiety 
which is common to all soluble VSGs but is cryptic 
on the respective membrane form [4,6,7]. 
The aim of the present study was to determine 
whether phospholipase C from T. brucei could 
convert ~phiphilic DS-AChE into its hydrophilic 
form and if the crossreacting determinant could 
then be detected on vertebrate AChE. Such fin- 
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dings would strongly support the existence of a 
common membr~e-anchoring system for these 
two genetically distant membrane proteins. 
2. MATERIALS AND METHODS 
DS-AChE and proteinase K solubifized AChE 
from Torpedo marmorata were purified according 
to [8] and DS-AChE from human erythrocyte 
membranes as described in [9]. AChE activity was 
monitored according to Ellman et al. [IO], mem- 
brane form VSG (ILTat 1.25) was prepared as 
described 171; phospholipase C type III from B. 
cereus was from Sigma. ~hospho~pase C from 
MIT& 1.6 T, l~~ei tr~anosomes (5 x 1O’e) was 
prepared by h~otonic~ly lysing the cells and in- 
ducing maximum VSG release. After centrifuga- 
tion at 100 000 x g the pelleted material was resus- 
pended in 15 ml of precondensed PO Triton X-l 14 
in 10 mM Tris-HCI, 150 mM NaCI, pH 7.4 (TBS) 
at 0°C and centrifuged at 100000 x g for 1 h at 
4YZ. The supernatant was subjected to phase 
separation [l 11. The lipase activity was essentially 
recovered in the detergent phase containing 12% 
Triton X-l 14. It was kept at - 20QC until required, 
Antibodies directed against he crossreacting deter- 
minant of solubfe VSGs of T. brucei were raised in 
rabbits and purified as described in [4]. To remove 
a small population of antibodies which could bind 
the membrane form VSG, the preparation was 
then applied to MITat 1.6 membrane form VSC 
immobilized on Sepharose 4B and the flow through 
of this column was used in the experiments. 
Incubation with phospholipase C was performed 
in TBS containing 0.08% Triton X-100 for 60 min 
at 27°C in a final volume of 20~1. Thereafter 200 
pl of a 4% solution of Triton X-114 in TBS were 
added and the phase separation was effected at 
37°C I[llf+ Immunoblots of the same sheets were 
revealed after overnight incubation with 2 ygi’ml 
of antibodies against the crossreacting determinant 
followed by protein A-peroxidase conjugate (Sig- 
ma) [12,13]. 
3. RESULTS 
We have purified detergent soluble, amphiphilic 
AChE from the electric organ of Tar. marmoruta 
and from human red cell membranes and subjected 
them to treatment with pbospholi~ase C from B, 
cereus and T. brucei. The conversion of the am- 
phiphilic form of AChE to a hydrophilic one was 
assessed by phase separation using T&on X-l 14 
fl 1 f _ In this system ~phiphi~ic proteins are 
recovered in the detergent phase whereas hydro- 
philic ones partition into the aqueous phase. Fig, 1 
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Fig-f. Conversian of amph~ph~~ic DS-AChE to the 
hydrophilic form by phospholipase C assessed by phase 
separation in Triton X-114. Pure DS-AChE from Tar, 
murmorata (A) and from human erythrocyte mem- 
branes (0) were incubated with various concentrations 
of phospholipase C from B. cereus (top) and 2: brucei 
(bottom). After 60 min at 27”C, the samples were sub- 
jected to phase separation in Triton X-l 14 and the parti- 
tion of AChE activity was measured. The sum of ac- 
tivities in both phases remained constant. Proteinase K 
sohrbilized, hydrophilic AChE from Tar. rn~rrn~ru~~ 
sewed as a control (r)_ 
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shows that increasing amounts of phospholipase C 
from B. cereus as well as from T. brucei pro- 
gressively converted amphiphilic DS-AChE from 
Torpedo to a catalytically active hydrophilic en- 
zyme. On the other hand, the enzyme from human 
red cell membranes was less sensitive to phospho- 
lipase C treatment as in similar conditions, only a 
small increase in AChE activity in the aqueous 
phase was obtained. Proteinase K solubilized, 
hydrophilic AChE from Torpedo served as con- 
trol. This form of the enzyme was always 
recovered in the aqueous phase independent of the 
absence or presence of phospholipase C in the in- 
cubation medium. Fig.2 shows the time course of 
conversion of the amphiphilic DS-AChE to the 
I---+- 
incubation time (h) 
Fig.2. Time course of conversion of amphiphilic DS- 
AChE to the hydrophilic form by phospholipase C from 
T. brucei. DS-AChE from Tor. marmorata was in- 
cubated without (A) and with 1.6 pi/ml phospholipase C 
(A); DS-AChE from human erythrocyte membranes 
without (0) and with lOpl/ml phospholipase C (0). At 
the times indicated aliquots were subjected to phase 
separation in Triton X-114 and the partition of AChE 
activity was measured. The sum of activities in both 
phases remained constant. 
hydrophilic form by phospholipase C from T. 
brucei. In our conditions about 80% of DS-AChE 
from Torpedo became hydrophilic within 24 h in- 
cubation. On the other hand, only a small amount 
of DS-AChE from human erythrocyte membranes 
was converted to a form that partitioned into the 
aqueous phase although the concentration of 
phospholipase C was 6-fold higher than in the ex- 
periment with DS-AChE from Torpedo. 
Different samples of AChE were incubated 
without and with B. cereus or T. brucei phospho- 
lipase C, thereafter analyzed by SDS-polyacryl- 
amide gel electrophoresis and transferred to nitro- 
cellulose. Fig.3 (top) shows the protein stain of the 
blot. The blot was then destained and the exposure 
of the crossreacting determinant on the different 
proteins was revealed with anti-crossreacting deter- 
minant antibodies (fig.3, bottom). Lane 1 shows 
that native DS-AChE from Torpedo did not react 
with antibodies against the crossreacting determi- 
nant. However, treatment with phospholipase C 
from B. cereus (lane 2) as well as with phospho- 
12 3 4 5 0 
Fig.3. Disclosure of the crossreacting determinant on 
hydrophilic AChE following phospholipase C treat- 
ment. Amphiphilic DS-AChE (lanes l-3) and proteinase 
K solubilized, hydrophilic AChE from Tor. marmorata 
(lanes 4-6), DS-AChE from human erythrocyte mem- 
branes (lanes 7-9) and membrane form VSG (ILTat 
1.25) from T. brucei (lanes 10-12) were incubated in 
absence (lanes 1,4,7,10) or presence of phospholipase C 
from B. cereus (lanes 2,5,8,11) or phospholipase C from 
T. brucei (lanes 3.6,9,12). The samples were then sub- 
jected to SDS-polyacrylamide gel electrophoresis, trans- 
ferred to nitrocellulose and thereon stained for protein 
with Ponceau S (top). Bottom, corresponding immuno- 
blot obtained by incubation with antibodies against the 
crossreacting determinant of soluble VSG of T. brucei. 
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lipase C from T. brucei (lane 3) yielded a form of 
AChE that crossreacted with these antibodies. On 
the other hand, proteinase K-treated AChE from 
Torpedo did not crossreact independent of the 
absence (lane 4) or presence of phospholipase C 
(lanes 5 and 6) in the incubation mixture. Lane 7 
shows native AChE from human red cell mem- 
branes prior to treatment with phospholipase C. It 
also revealed the crossreacting determinant after 
treatment with phospholipase C from T. brucei 
(lane 9) but no reaction could be detected after 
treatment with phospholipase C from B. cereus 
(lane 8). VSG from T. brucei served as control. In 
the absence of phospholipase C only a faint band 
in the immunoblot was obtained (lane 10) whereas 
a strong reaction was observed after treatment 
with the two phospholipases C (lanes 11 and 12). 
4. DISCUSSION 
The glycophospholipid which anchors the mem- 
brane form VSGs to the membrane of T. brucei is 
cleaved by the action of an endogenous phospho- 
lipase C thereby converting the membrane form 
VSG to the soluble VSG and concomitantly expos- 
ing the crossreacting determinant [4,6,7]. The 
membrane-bound amphiphilic form of AChE is 
solubilized by PI-specific phospholipase C from 
different sources [14-161. In addition other mem- 
brane proteins such as alkaline phosphatase, 5 ’ - 
nucleotidase [14], Thy-l glycoprotein [17] and p63 
from Leishmania major [18] are also converted to 
a hydrophilic form by PI-specific phospholipase 
C. It appears likely that the attachment of these 
different proteins to membranes involves a com- 
mon anchoring mechanism, i.e. a glycophospho- 
lipid covalently attached to the protein moiety [ 191. 
Our results show that Torpedo DS-AChE is effi- 
ciently transformed into a hydrophilic molecule by 
the action of T. brucei phospholipase C. Human 
erythrocyte AChE, on the other hand, is a poor 
substrate for the enzyme. The difference in suscep- 
tibility may be due to a specificity of the am- 
phiphilic T. brucei lipase for the length of the fatty 
acids of the lipid anchor which are different in the 
erythrocyte AChE [20] and in the membrane form 
VSG [5]. Alternatively, a slightly different or 
heterogenous crossreacting determinant or a dif- 
ferent accessibility of the cleavage site to phospho- 
lipase C could also influence the rate and the extent 
of the reaction. The results obtained with pro- 
teinase K-digested DS-AChE from Torpedo sug- 
gest that the 3 kDa hydrophobic entity removed by 
proteinase K [21] contained the phospholipid and 
the crossreacting determinant. The presumed C- 
terminal location of this moiety is consistent with 
the known location of the glycophospholipid in the 
membrane form VSG [6]. 
In contrast to Ferguson et al. [5] who failed to 
show that the crossreacting determinant was ex- 
posed on AChE from Torpedo after digestion with 
PI-specific phospholipase C from Staphylococcus 
aureus, we found that the anti-crossreacting deter- 
minant antibodies reacted strongly with AChE 
after digestion with both T. brucei and B. cereus 
phospholipase C. The same result was obtained 
with human erythrocyte AChE digested with T. 
brucei lipase indicating that an analogous glyco- 
phospholipid can also be found in mammalian 
cells. It further suggests that the complex biosyn- 
thetic pathway, proposed for T. brucei VSG [22] 
may also be found in higher organisms. 
From our results we conclude that the anchoring 
of proteins to membranes via a glycophospholipid 
moiety has been conserved through evolution. A 
possible advantage of such a protein-membrane at- 
tachment may be that membrane proteins could be 
specifically released by the action of an endo- 
genous phospholipase C. This is of importance for 
trypanosomes that lose their surface coat during 
differentiation into procyclics [23]. In cells of 
neuronal origin a secretory form of AChE has 
been described [24]. It is tempting to speculate that 
this secretory process might involve a phospho- 
lipase C-mediated cleavage of the hydrophobic an- 
chor of AChE. 
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